130 related articles for article (PubMed ID: 16256137)
21. Assessment of ret/PTC-1 rearrangements in neoplastic thyroid tissue using TaqMan RT-PCR.
Sheils OM; O'Leary JJ; Sweeney EC
J Pathol; 2000 Sep; 192(1):32-6. PubMed ID: 10951397
[TBL] [Abstract][Full Text] [Related]
22. Rearrangements of NTRK1 gene in papillary thyroid carcinoma.
Greco A; Miranda C; Pierotti MA
Mol Cell Endocrinol; 2010 May; 321(1):44-9. PubMed ID: 19883730
[TBL] [Abstract][Full Text] [Related]
23. Transcript level modulates the inherent oncogenicity of RET/PTC oncoproteins.
Richardson DS; Gujral TS; Peng S; Asa SL; Mulligan LM
Cancer Res; 2009 Jun; 69(11):4861-9. PubMed ID: 19487296
[TBL] [Abstract][Full Text] [Related]
24. Conditional activation of RET/PTC3 and BRAFV600E in thyroid cells is associated with gene expression profiles that predict a preferential role of BRAF in extracellular matrix remodeling.
Mesa C; Mirza M; Mitsutake N; Sartor M; Medvedovic M; Tomlinson C; Knauf JA; Weber GF; Fagin JA
Cancer Res; 2006 Jul; 66(13):6521-9. PubMed ID: 16818623
[TBL] [Abstract][Full Text] [Related]
25.
Pekova B; Sykorova V; Dvorakova S; Vaclavikova E; Moravcova J; Katra R; Astl J; Vlcek P; Kodetova D; Vcelak J; Bendlova B
Thyroid; 2020 Dec; 30(12):1771-1780. PubMed ID: 32495721
[No Abstract] [Full Text] [Related]
26. The TRK-T1 fusion protein induces neoplastic transformation of thyroid epithelium.
Russell JP; Powell DJ; Cunnane M; Greco A; Portella G; Santoro M; Fusco A; Rothstein JL
Oncogene; 2000 Nov; 19(50):5729-35. PubMed ID: 11126359
[TBL] [Abstract][Full Text] [Related]
27. Low frequency of rearrangements of the ret and trk proto-oncogenes in Japanese thyroid papillary carcinomas.
Wajjwalku W; Nakamura S; Hasegawa Y; Miyazaki K; Satoh Y; Funahashi H; Matsuyama M; Takahashi M
Jpn J Cancer Res; 1992 Jul; 83(7):671-5. PubMed ID: 1381340
[TBL] [Abstract][Full Text] [Related]
28. RET/NTRK1 rearrangements in thyroid gland tumors of the papillary carcinoma family: correlation with clinicopathological features.
Bongarzone I; Vigneri P; Mariani L; Collini P; Pilotti S; Pierotti MA
Clin Cancer Res; 1998 Jan; 4(1):223-8. PubMed ID: 9516975
[TBL] [Abstract][Full Text] [Related]
29. A sequence analysis of the genomic regions involved in the rearrangements between TPM3 and NTRK1 genes producing TRK oncogenes in papillary thyroid carcinomas.
Butti MG; Bongarzone I; Ferraresi G; Mondellini P; Borrello MG; Pierotti MA
Genomics; 1995 Jul; 28(1):15-24. PubMed ID: 7590742
[TBL] [Abstract][Full Text] [Related]
30. The prevalence of RET/PTC mutations in papillary thyroid cancers in Turkish population and its relation between tumor histopathology and prognostic factors.
Erdoğan M; Berdeli A; Karadeniz M; Ertan Y; Cetinkalp S; Saygili F; Tuncyurek M; Yilmaz C; Tuzun M; Kabalak T; Uluer H; Ozgen AG
Exp Clin Endocrinol Diabetes; 2008 Apr; 116(4):225-30. PubMed ID: 18393128
[TBL] [Abstract][Full Text] [Related]
31. Proximity of TPR and NTRK1 rearranging loci in human thyrocytes.
Roccato E; Bressan P; Sabatella G; Rumio C; Vizzotto L; Pierotti MA; Greco A
Cancer Res; 2005 Apr; 65(7):2572-6. PubMed ID: 15805251
[TBL] [Abstract][Full Text] [Related]
32. RET/PTC fusion gene rearrangements in Japanese thyroid carcinomas.
Nibu K; Otsuki N; Nakao K; Sugasawa M; Rothstein JL
Eur Arch Otorhinolaryngol; 2005 May; 262(5):368-73. PubMed ID: 15368067
[TBL] [Abstract][Full Text] [Related]
33. RET/PTC and RET tyrosine kinase expression in adult papillary thyroid carcinomas.
Learoyd DL; Messina M; Zedenius J; Guinea AI; Delbridge LW; Robinson BG
J Clin Endocrinol Metab; 1998 Oct; 83(10):3631-5. PubMed ID: 9768676
[TBL] [Abstract][Full Text] [Related]
34. Gene expression in RET/PTC3 and E7 transgenic mouse thyroids: RET/PTC3 but not E7 tumors are partial and transient models of human papillary thyroid cancers.
Burniat A; Jin L; Detours V; Driessens N; Goffard JC; Santoro M; Rothstein J; Dumont JE; Miot F; Corvilain B
Endocrinology; 2008 Oct; 149(10):5107-17. PubMed ID: 18583418
[TBL] [Abstract][Full Text] [Related]
35. Identification of Three Novel Fusion Oncogenes, SQSTM1/NTRK3, AFAP1L2/RET, and PPFIBP2/RET, in Thyroid Cancers of Young Patients in Fukushima.
Iyama K; Matsuse M; Mitsutake N; Rogounovitch T; Saenko V; Suzuki K; Ashizawa M; Ookouchi C; Suzuki S; Mizunuma H; Fukushima T; Suzuki S; Yamashita S
Thyroid; 2017 Jun; 27(6):811-818. PubMed ID: 28351223
[TBL] [Abstract][Full Text] [Related]
36. Clinicopathological features and immunohistochemical utility of NTRK-, ALK-, and ROS1-rearranged papillary thyroid carcinomas and anaplastic thyroid carcinomas.
Nozaki Y; Yamamoto H; Iwasaki T; Sato M; Jiromaru R; Hongo T; Yasumatsu R; Oda Y
Hum Pathol; 2020 Dec; 106():82-92. PubMed ID: 32980422
[TBL] [Abstract][Full Text] [Related]
37. Searching for non-RET molecular alterations in medullary thyroid carcinoma: expression analysis by mRNA differential display.
Musholt TJ; Hanack J; Brehm C; von Wasielewski R; Musholt PB
World J Surg; 2005 Apr; 29(4):472-82. PubMed ID: 15776290
[TBL] [Abstract][Full Text] [Related]
38. NTRK1 re-arrangement in papillary thyroid carcinomas of children after the Chernobyl reactor accident.
Beimfohr C; Klugbauer S; Demidchik EP; Lengfelder E; Rabes HM
Int J Cancer; 1999 Mar; 80(6):842-7. PubMed ID: 10074915
[TBL] [Abstract][Full Text] [Related]
39. Ret and trk proto-oncogene activation in thyroid papillary carcinomas in French patients from the Champagne-Ardenne region.
Delvincourt C; Patey M; Flament JB; Suarez HG; Larbre H; Jardillier JC; Delisle MJ
Clin Biochem; 1996 Jun; 29(3):267-71. PubMed ID: 8740514
[TBL] [Abstract][Full Text] [Related]
40. Rearrangements of RET and NTRK1 tyrosine kinase receptors in papillary thyroid carcinomas.
Pierotti MA; Vigneri P; Bongarzone I
Recent Results Cancer Res; 1998; 154():237-47. PubMed ID: 10027004
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
